Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Normal development of the human central nervous system (CNS) encompasses several steps, including neuroectoderm induction, neurulation, cell proliferation and migration, programmed cell death, neurogenesis and elimination of excess neurons, synaptogenesis, stabilization and elimination of synapses, gliogenesis, and myelination ( Table 51.1 ).
Neuroectoderm induction | 3rd GW |
Neurulation | 3rd to end of 4th GW |
Prosencephalic and hemispheric formation | 5th to 10th GW |
Neuronal proliferation | 10th to 20th GW (?10th to end of gestation for interneurons) |
Neuronal migration | 12th to 24th GW (?10th to 41st GW for interneurons) |
Programmed neuronal cell death | 28th to 41st GW |
Synaptogenesis | 20th GW to puberty |
Gliogenesis | 20th to 24th GW to ?postnatal years |
Myelination | 36th to 38th GW to 2 to 3 postnatal years |
Angiogenesis | 5th to 10th GW to ?postnatal years |
These different steps of brain development and maturation are controlled by the interaction between genes and the environment. Numerous genes involved in brain development have been identified: genes controlling neurulation, neuronal proliferation, neuronal size and shape, programmed cell death, neuronal–glial interactions, and synaptic stabilization. However, it seems unlikely that the 30,000 genes in humans can totally control the organization of 100 billion neurons and trillions of synapses. A normal pattern of expression of these genes requires an adequate environment. Interactions with the intrauterine milieu (factors coming from the mother, placenta, or amniotic fluid) and with the postnatal environment critically modulate gene expression through reciprocal action with neurotransmitters, trophic factors, and hormones and their machinery. Accordingly, brain malformations can be due to environmental factors, genetic factors, or an interaction of both ( Boxes 51.1 through 51.4 ).
Retinoic acid
Antithyroid drugs
Estroprogestative hormones, testosterone, and derivatives
Antimitotic drugs
Lithium and psychotropic drugs
Benzodiazepines and antiepileptic drugs
Tobacco
Caffeine
Ethanol
Cocaine
Opiates
Cannabis
Dioxins and heavy metals
Organic solvents
Ionizing radiation
Head trauma
Repeated shaking
Sex hormones
Catecholamines
Thyroid hormones
Diabetes mellitus
Peptides (vasoactive intestinal peptide)
Placenta and decidual hormones
Oxygen and hypoxia–ischemia
Hyperthermia
Herpes simplex virus I and II
Herpes zoster virus
Cytomegalovirus
Rubella virus
Parvovirus B19
Coxsackie virus, B group
Human immunodeficiency virus
Influenza virus
Benign lymphocytic meningitis virus
Toxoplasma gondii
Listeria monocytogenes
Treponema pallidum
Chromosome 13: trisomy, deletion or duplication of 13q, ring
Deletion 2p, duplication 3p, deletion 7q, deletion 21q
Triploidy
Meckel syndrome
Varadi-Papp syndrome
Pallister-Hall syndrome
Smith-Lemli-Opitz syndrome
Velo-cardio-facial syndrome
SIX3: HPE2 locus on chromosome 2p21
SHH: HPE3 locus on chromosome 7q36
TGIF: HPE4 locus on chromosome 18p11.3
ZIC2: HPE5 locus on chromosome 13q32
Hypocholesterolemia
Retinoic acid exposure
Ethanol exposure
MCPH1 (Microcephaly) , WDR62 (MCPH2) , CDK5RAP2 (MCPH3), CASC5 (MCPH4) , ASPM (MCPH5), CENPJ (MCPH6), STIL (MCPH7), CEP135 (MCPH8), CEP152 (MCPH9), ZNF335 (MCPH10), PHC1 (MCPH11), CDK6 (MCPH12), CENPE (MCPH13) , SASS6 (MCPH14) , MFSD2A (MCPH15), ANKLE2 (MCPH16), CIT (MCPH17), WDFY3 (MCPH18).
Seckel syndrome: ATR (SCKL1), RBBP8 (SCKL2), CENPJ (SCKL4), CEP152 (SCKL5), CEP63 (SCKL6), NIN (SCKL7), DNA2 (SCKL8), TRAIP (SCKL9), NSMCE2 (SCKL10),
Microcephalic osteodysplastic primordial dwarfism: PCNT
Meier Gorlin syndrome: ORC1 (MGORS1), ORC4 (MGORS2), ORC6 (MGORS3), CDT1 (MGORS4), CDC6 (MGORS5), GMNN (MGORS6), CDC45L (MGORS7), MCM5 (MGORS8).
Normal or thin corpus callosum
Agenesis of the corpus callosum
With thin cortex: RELN (MILIS1 or Norman Roberts syndrome)
With thin cortex, brainstem and cerebellar hypoplasia (MLIS2 or Barth syndrome)
With intermediate cortex (MLIS3)
With mildly to moderately thin cortex (MLIS4)
Neu-Laxova syndrome (autosomal recessive)
PHGDH (NLS1), PSAT1 (NLS2)
Rubinstein-Taybi syndrome (autosomal dominant)
CREBBP (RSTS1), EP300 (RSTS2)
Cornelia de Lange syndrome (autosomal dominant except for CDLS X-linked)
NIPBL (CDLS1), SMC1A (CDLS2), SMC3 (CDLS3), RAD21 (CDLS4), HDAC8 (CDLS5).
Hypoxia–ischemia
Severe malnutrition
Maternal hyperphenylalaninemia and phenylketonuria
Ionizing radiation
Ethanol exposure
Infections (cytomegalovirus, benign lymphocytic meningitis virus, Toxoplasma gondii , Rubella virus, Zika virus)
FLNA (X-linked)
With microcephaly: ARFGEF2 (autosomal recessive)
LIS1 (autosomal dominant)
DCX (X-linked)
TUBA3 (autosomal dominant)
ARX (X-linked)
POMT1
POMT2
FCMD (FKTN)
FKRP
POMGNT1
POMGNT2
DAG1
ISPD
LAMB1
POMK
RXYLT1
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here